Injectable PLGA Microparticles vs. Oral Tablets for Ivacaftor Delivery in CF Treatment
發布者：Unknown
·發布於：2025-12-13
A discussion regarding the potential benefits of using an injectable long-acting PLGA microparticle formulation for delivering ivacaftor compared to conventional oral tablet administration in the treatment of cystic fibrosis.
載入中...